PATENT CLAIM ANALYSIS

Application Number: 16037368
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.

Claim (Index 10):
The compound of  claim 1 , wherein each R 5  is independently halogen, C 1-6  aliphatic, C 3-10  aryl, a 3-8 membered saturated or partially unsaturated carbocyclic ring, a 3-7 membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which is optionally substituted.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15381406', '15620049', '15016569', '15680683', '15267606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972987373410876
- 35 USC 102 Novelty (BERT): 0.5520862781891551
- Combined Prediction Score: 0.7727774914258944
- Mean Citation Score: 329.576652
- Max Citation Score: 412.4425
- Similarity Product: 352.8558109077811

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test